The microbiome and cancer (original) (raw)

• Koch, R. in Tenth International Congress of Medicine 1 (August Hirschwald, Berlin, 1891).
  Google Scholar
• Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539–545 (2001).
  Article CAS PubMed Google Scholar
• Trinchieri, G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 30, 677–706 (2012).
  Article CAS PubMed Google Scholar
• Moore, P. S. & Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nature Rev. Cancer 10, 878–889 (2010).
  Article CAS Google Scholar
• Virchow, R. in Die krankhaften Geschwülste (ed. Virchow, R.) 57–101 (Verlag von August von Hirschwald, Berlin, 1863).
  Google Scholar
• Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).
  Article PubMed Google Scholar
• Smith, M. I. et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339, 548–554 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• O'Hara, A. M. & Shanahan, F. The gut flora as a forgotten organ. EMBO Rep. 7, 688–693 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Savage, D. C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31, 107–133 (1977).
  Article CAS PubMed Google Scholar
• Gill, S. R. et al. Metagenomic analysis of the human distal gut microbiome. Science 312, 1355–1359 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L. & Gordon, J. I. Human nutrition, the gut microbiome and the immune system. Nature 474, 327–336 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Fraher, M. H., O'Toole, P. W. & Quigley, E. M. Techniques used to characterize the gut microbiota: a guide for the clinician. Nature Rev. Gastroenterol. Hepatol 9, 312–322 (2012).
  Article CAS Google Scholar
• Consortium, H. M. P. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).
  Article CAS Google Scholar
• Colditz, G. A., Sellers, T. A. & Trapido, E. Epidemiology — identifying the causes and preventability of cancer? Nature Rev. Cancer 6, 75–83 (2006).
  Article CAS Google Scholar
• Peto, J. Cancer epidemiology in the last century and the next decade. Nature 411, 390–395 (2001).
  Article CAS PubMed Google Scholar
• Grice, E. A. & Segre, J. A. The skin microbiome. Nature Rev. Microbiol. 9, 244–253 (2011).
  Article CAS Google Scholar
• Eckburg, P. B. et al. Diversity of the human intestinal microbial flora. Science 308, 1635–1638 (2005).
  Article PubMed PubMed Central Google Scholar
• Wiest, R. & Garcia-Tsao, G. Bacterial translocation (BT) in cirrhosis. Hepatology 41, 422–433 (2005).
  Article CAS PubMed Google Scholar
• Seki, E. et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nature Med. 13, 1324–1332 (2007).
  Article CAS PubMed Google Scholar
• Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504–516 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97–101 (2013).
  Article CAS PubMed Google Scholar
• Sacksteder, M. R. Occurrence of spontaneous tumors in the germfree F344 rat. J. Natl Cancer Inst. 57, 1371–1373 (1976).
  Article CAS PubMed Google Scholar
• Schreiber, H., Nettesheim, P., Lijinsky, W., Richter, C. B. & Walburg, H. E. Jr Induction of lung cancer in germfree, specific-pathogen-free, and infected rats by _N_-nitrosoheptamethyleneimine: enhancement by respiratory infection. J. Natl Cancer Inst. 49, 1107–1114 (1972).
  CAS PubMed Google Scholar
• Reddy, B. S. et al. Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res. 35, 287–290 (1975).
  CAS PubMed Google Scholar
• Reddy, B. S. & Watanabe, K. Effect of intestinal microflora on 2,2′-dimethyl-4-aminobiphenyl-induced carcinogenesis in F344 rats. J. Natl Cancer Inst. 61, 1269–1271 (1978).
  Article CAS PubMed Google Scholar
• Reddy, B. S., Weisburger, J. H., Narisawa, T. & Wynder, E. L. Colon carcinogenesis in germ-free rats with 1,2-dimethylhydrazine and _N_-methyl-_N_′-nitro-_N_-nitrosoguanidine. Cancer Res. 34, 2368–2372 (1974).
  CAS PubMed Google Scholar
• Laqueur, G. L., Matsumoto, H. & Yamamoto, R. S. Comparison of the carcinogenicity of methylazoxymethanol-β-D-glucosiduronic acid in conventional and germfree Sprague-Dawley rats. J. Natl Cancer Inst. 67, 1053–1055 (1981).
  CAS PubMed Google Scholar
• Uronis, J. M. et al. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE 4, e6026 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Lofgren, J. L. et al. Lack of commensal flora in _Helicobacter pylori_-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology 140, 210–220 (2011).
  Article PubMed Google Scholar
• Li, Y. et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in _APC_Min/+ mice. Carcinogenesis 33, 1231–1238 (2012).
  Article CAS PubMed Google Scholar
• Vannucci, L. et al. Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity. Int. J. Oncol. 32, 609–617 (2008).
  PubMed Google Scholar
• Dove, W. F. et al. Intestinal neoplasia in the _Apc_Min mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res. 57, 812–814 (1997).
  CAS PubMed Google Scholar
• Chen, G. Y., Shaw, M. H., Redondo, G. & Nunez, G. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res. 68, 10060–10067 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, L. X. et al. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 52, 1322–1333 (2010).
  Article CAS PubMed Google Scholar
• Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254–258 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Klimesova, K. et al. Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice. Inflamm. Bowel Dis. 19, 1266–1277 (2013).
  Article PubMed Google Scholar
• Lee, C. W. et al. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 68, 3540–3548 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ma, J. L. et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J. Natl Cancer Inst. 104, 488–492 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wong, B. C. et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291, 187–194 (2004).
  Article CAS PubMed Google Scholar
• Coley, W. B. Treatment of inoperable malignant tumors with the toxins of erysipelas and the Bacillus prodigiosus. Trans. Amer. Surg. Assn 12, 183–212 (1894).
  Google Scholar
• Starnes, C. O. Coley's toxins in perspective. Nature 357, 11–12 (1992).
  Article CAS PubMed Google Scholar
• Shear, M. J. & Andervont, H. B. Chemical treatment of tumors. III. separation of hemorrhage-producing fraction of B. coli filtrate. Exp. Biol. Med. (Maywood) 34, 323–324 (1936).
  Article CAS Google Scholar
• Pradere, J. P., Dapito, D. H. & Schwabe, R. F. The yin and yang of toll-like receptors in cancer. Oncogene http://dx.doi.org/10.1038/onc.2013.302 (2013).
• Garaude, J., Kent, A., van Rooijen, N. & Blander, J. M. Simultaneous targeting of Toll- and NOD-like receptors induces effective tumor-specific immune responses. Sci. Transl. Med. 4, 120ra16 (2012).
  Article PubMed CAS Google Scholar
• Peek, R. M. Jr & Blaser, M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Rev. Cancer 2, 28–37 (2002).
  Article CAS Google Scholar
• Fox, J. G. & Wang, T. C. Inflammation, atrophy, and gastric cancer. J. Clin. Invest. 117, 60–69 (2007).
  Article CAS PubMed Google Scholar
• Islami, F. & Kamangar, F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev. Res. (Phila) 1, 329–338 (2008).
  Article CAS Google Scholar
• Caygill, C. P., Hill, M. J., Braddick, M. & Sharp, J. C. Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet 343, 83–84 (1994).
  Article CAS PubMed Google Scholar
• Welton, J. C., Marr, J. S. & Friedman, S. M. Association between hepatobiliary cancer and typhoid carrier state. Lancet 1, 791–794 (1979).
  Article CAS PubMed Google Scholar
• Wotherspoon, A. C. et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575–577 (1993).
  Article CAS PubMed Google Scholar
• Lecuit, M. et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 350, 239–248 (2004).
  Article CAS PubMed Google Scholar
• Senff, N. J. et al. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood 112, 1600–1609 (2008).
  Article CAS PubMed Google Scholar
• Ferreri, A. J. et al. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J. Clin. Oncol. 30, 2988–2994 (2012).
  Article CAS PubMed Google Scholar
• Grivennikov, S. I. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin. Immunopathol. 35, 229–244 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Ochi, A. et al. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J. Exp. Med. 209, 1671–1687 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Michaud, D. S., Joshipura, K., Giovannucci, E. & Fuchs, C. S. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J. Natl Cancer Inst. 99, 171–175 (2007).
  Article PubMed Google Scholar
• Farrell, J. J. et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 61, 582–588 (2012).
  Article CAS PubMed Google Scholar
• Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C. & Isaacson, R. E. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS ONE 7, e47305 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sethi, S. & Murphy, T. F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 2355–2365 (2008).
  Article CAS PubMed Google Scholar
• Houghton, A. M. Mechanistic links between COPD and lung cancer. Nature Rev. Cancer 13, 233–245 (2013).
  Article CAS PubMed Google Scholar
• Melkamu, T., Qian, X., Upadhyaya, P., O'Sullivan, M. G. & Kassie, F. Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation- driven lung cancer. Vet. Pathol. 50, 895–902 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Swann, J. B. et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc. Natl Acad. Sci. USA 105, 652–656 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Mittal, D. et al. TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J. 29, 2242–2252 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cataisson, C. et al. IL-1R–MyD88 signaling in keratinocyte transformation and carcinogenesis. J. Exp. Med. 209, 1689–1702 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host–bacterial mutualism in the human intestine. Science 307, 1915–1920 (2005).
  Article CAS PubMed Google Scholar
• Dethlefsen, L., McFall-Ngai, M. & Relman, D. A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449, 811–818 (2007).
  Article CAS PubMed Google Scholar
• Eloe-Fadrosh, E. A. & Rasko, D. A. The human microbiome: from symbiosis to pathogenesis. Annu. Rev. Med. 64, 145–163 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Salzman, N. H., Underwood, M. A. & Bevins, C. L. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin. Immunol. 19, 70–83 (2007).
  Article CAS PubMed Google Scholar
• Nestle, F. O., Di Meglio, P., Qin, J. Z. & Nickoloff, B. J. Skin immune sentinels in health and disease. Nature Rev. Immunol. 9, 679–691 (2009).
  Article CAS Google Scholar
• Littman, D. R. & Rudensky, A. Y. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140, 845–858 (2010).
  Article CAS PubMed Google Scholar
• Pabst, O. New concepts in the generation and functions of IgA. Nature Rev. Immunol. 12, 821–832 (2012).
  Article CAS Google Scholar
• Ashida, H., Ogawa, M., Kim, M., Mimuro, H. & Sasakawa, C. Bacteria and host interactions in the gut epithelial barrier. Nature Chem. Biol. 8, 36–45 (2011).
  Article CAS Google Scholar
• van Nood, E. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407–415 (2013).
  Article CAS PubMed Google Scholar
• Kamada, N. et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336, 1325–1329 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cornforth, D. M. & Foster, K. R. Competition sensing: the social side of bacterial stress responses. Nature Rev. Microbiol. 11, 285–293 (2013).
  Article CAS Google Scholar
• Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120–123 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Couturier-Maillard, A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123, 700–711 (2013).
  CAS PubMed PubMed Central Google Scholar
• Hu, B. et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc. Natl Acad. Sci. USA 110, 9862–9867 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307–317 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Houlston, R. S. et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nature Genet. 42, 973–977 (2010).
  Article CAS PubMed Google Scholar
• Peters, U. et al. Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology 144, 799–807 (2013).
  Article CAS PubMed Google Scholar
• Velcich, A. et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295, 1726–1729 (2002).
  Article CAS PubMed Google Scholar
• Irvine, A. D., McLean, W. H. & Leung, D. Y. Filaggrin mutations associated with skin and allergic diseases. N. Engl. J. Med. 365, 1315–1327 (2011).
  Article CAS PubMed Google Scholar
• Costello, E. K. et al. Bacterial community variation in human body habitats across space and time. Science 326, 1694–1697 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Caporaso, J. G. et al. Moving pictures of the human microbiome. Genome Biol. 12, R50 (2011).
  Article PubMed PubMed Central Google Scholar
• Holmes, E., Li, J. V., Marchesi, J. R. & Nicholson, J. K. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell. Metab. 16, 559–564 (2012).
  Article CAS PubMed Google Scholar
• Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).
  Article CAS PubMed Google Scholar
• Ward, J. M. et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl Cancer Inst. 86, 1222–1227 (1994).
  Article CAS PubMed Google Scholar
• Erdman, S. E. et al. Nitric oxide and TNF-α trigger colonic inflammation and carcinogenesis in _Helicobacter hepaticus_-infected, Rag2-deficient mice. Proc. Natl Acad. Sci. USA 106, 1027–1032 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, S. C. et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128, 891–906 (2005).
  Article CAS PubMed Google Scholar
• Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature Med. 15, 1016–1022 (2009).
  Article CAS PubMed Google Scholar
• Boulard, O., Kirchberger, S., Royston, D. J., Maloy, K. J. & Powrie, F. M. Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation. J. Exp. Med. 209, 1309–1324 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Rao, V. P. et al. Proinflammatory CD4+ CD45RBhi lymphocytes promote mammary and intestinal carcinogenesis in _Apc_Min/+ mice. Cancer Res. 66, 57–61 (2006).
  Article CAS PubMed Google Scholar
• Garrett, W. S. et al. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 16, 208–219 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, H. L. et al. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J. Hepatol 57, 803–812 (2012).
  Article PubMed Google Scholar
• Ley, R. E. et al. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102, 11070–11075 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Cotillard, A. et al. Dietary intervention impact on gut microbial gene richness. Nature 500, 585–588 (2013).
  Article CAS PubMed Google Scholar
• Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546 (2013).
  Article CAS PubMed Google Scholar
• Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Rev. Cancer 4, 579–591 (2004).
  Article CAS Google Scholar
• Devkota, S. et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice. Nature 487, 104–108 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, W., Liu, F., Ling, Z., Tong, X. & Xiang, C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 7, e39743 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sanapareddy, N. et al. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J. 6, 1858–1868 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sobhani, I. et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 6, e16393 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, T. et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6, 320–329 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207–215 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• McCoy, A. N. et al. Fusobacterium is associated with colorectal adenomas. PLoS ONE 8, e53653 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195–206 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Allen-Vercoe, E., Strauss, J. & Chadee, K. Fusobacterium nucleatum: an emerging gut pathogen? Gut Microbes 2, 294–298 (2011).
  Article PubMed Google Scholar
• Stecher, B. et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc. Natl Acad. Sci. USA 109, 1269–1274 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Elinav, E., Strowig, T., Henao-Mejia, J. & Flavell, R. A. Regulation of the antimicrobial response by NLR proteins. Immunity 34, 665–679 (2011).
  Article CAS PubMed Google Scholar
• Winter, S. E. et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339, 708–711 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Lupp, C. et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 204 (2007).
  Article CAS PubMed Google Scholar
• Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228–231 (2012).
  Article CAS Google Scholar
• Patwa, L. G. et al. Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli. Gastroenterology 141, 1842–1851 (2011).
  Article CAS PubMed Google Scholar
• Hajishengallis, G., Darveau, R. P. & Curtis, M. A. The keystone-pathogen hypothesis. Nature Rev. Microbiol. 10, 717–725 (2012).
  Article CAS Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  Article CAS PubMed Google Scholar
• Moresco, E. M., LaVine, D. & Beutler, B. Toll-like receptors. Curr. Biol. 21, R488–R493 (2011).
  Article CAS PubMed Google Scholar
• Fukata, M. et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133, 1869–1881 (2007).
  Article CAS PubMed Google Scholar
• Fukata, M. et al. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis. 17, 1464–1473 (2011).
  Article PubMed Google Scholar
• Tye, H. et al. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell 22, 466–478 (2012).
  Article CAS PubMed Google Scholar
• Ngo, V. N. et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115–119 (2011).
  Article CAS PubMed Google Scholar
• Brandl, K. et al. MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands. Proc. Natl Acad. Sci. USA 107, 19967–19972 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Neufert, C. et al. Tumor fibroblast–derived epiregulin promotes growth of colitis-associated neoplasms through ERK. J. Clin. Invest. 123, 1428–1443 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Naugler, W. E. et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121–124 (2007).
  Article CAS PubMed Google Scholar
• Rakoff-Nahoum, S. & Medzhitov, R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317, 124–127 (2007).
  Article CAS PubMed Google Scholar
• Lee, S. H. et al. ERK activation drives intestinal tumorigenesis in _Apc_min/+ mice. Nature Med. 16, 665–670 (2010).
  Article CAS PubMed Google Scholar
• Kennedy, C. L. et al. Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis. Oncogene http://dx.doi.org/10.1038/onc.2013.205 (2013).
• Salcedo, R. et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207, 1625–1636 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cho, J. H. The genetics and immunopathogenesis of inflammatory bowel disease. Nature Rev. Immunol. 8, 458–466 (2008).
  Article CAS Google Scholar
• Kobayashi, K. S. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731–734 (2005).
  Article CAS PubMed Google Scholar
• Petnicki-Ocwieja, T. et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl Acad. Sci. USA 106, 15813–15818 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Rehman, A. et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 60, 1354–1362 (2011).
  Article CAS PubMed Google Scholar
• McGovern, D. P. et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum. Mol. Genet. 14, 1245–1250 (2005).
  Article CAS PubMed Google Scholar
• Allen, I. C. et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207, 1045–1056 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Allen, I. C. et al. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity 36, 742–754 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hu, B. et al. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc. Natl Acad. Sci. USA 107, 21635–21640 (2010).
  Article PubMed PubMed Central Google Scholar
• Travaglione, S., Fabbri, A. & Fiorentini, C. The Rho-activating CNF1 toxin from pathogenic E. coli: a risk factor for human cancer development? Infect. Agent Cancer 3, 4 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Nesic, D., Hsu, Y. & Stebbins, C. E. Assembly and function of a bacterial genotoxin. Nature 429, 429–433 (2004).
  Article CAS PubMed Google Scholar
• Cuevas-Ramos, G. et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl Acad. Sci. USA 107, 11537–11542 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Smith, J. L. & Bayles, D. O. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit. Rev. Microbiol. 32, 227–248 (2006).
  Article CAS PubMed Google Scholar
• Elwell, C. A. & Dreyfus, L. A. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol. 37, 952–963 (2000).
  Article CAS PubMed Google Scholar
• Fox, J. G. et al. Gastroenteritis in NF-κB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect. Immun. 72, 1116–1125 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Shen, Z. et al. Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice. Infect. Immun. 77, 2508–2516 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Nougayrede, J. P. et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848–851 (2006).
  Article CAS PubMed Google Scholar
• Buc, E. et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE 8, e56964 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Garrett, W. S. et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8, 292–300 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Putze, J. et al. Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect. Immun. 77, 4696–4703 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Carbonero, F., Benefiel, A. C., Alizadeh-Ghamsari, A. H. & Gaskins, H. R. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front. Physiol. 3, 448 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Huycke, M. M. & Gaskins, H. R. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp. Biol. Med. (Maywood) 229, 586–597 (2004).
  Article CAS Google Scholar
• Wang, X. & Huycke, M. M. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 132, 551–561 (2007).
  Article CAS PubMed Google Scholar
• Wang, X. et al. 4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by _Enterococcus faecalis_-infected macrophages. Gastroenterology 142, 543–551 (2012).
  Article CAS PubMed Google Scholar
• Balish, E. & Warner, T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 160, 2253–2257 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299–306 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Attene-Ramos, M. S., Wagner, E. D., Plewa, M. J. & Gaskins, H. R. Evidence that hydrogen sulfide is a genotoxic agent. Mol. Cancer Res. 4, 9–14 (2006).
  Article CAS PubMed Google Scholar
• Ohnishi, N. et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl Acad. Sci. USA 105, 1003–1008 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Han, Y. W. et al. Identification and characterization of a novel adhesin unique to oral fusobacteria. J. Bacteriol. 187, 5330–5340 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Philipp, B. Bacterial degradation of bile salts. Appl. Microbiol. Biotechnol. 89, 903–915 (2011).
  Article CAS PubMed Google Scholar
• Bernstein, C. et al. Carcinogenicity of deoxycholate, a secondary bile acid. Arch. Toxicol. 85, 863–871 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Quante, M. et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 21, 36–51 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Nyangale, E. P., Mottram, D. S. & Gibson, G. R. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J. Proteome Res. 11, 5573–5585 (2012).
  Article CAS PubMed Google Scholar
• Windey, K., De Preter, V. & Verbeke, K. Relevance of protein fermentation to gut health. Mol. Nutr. Food Res. 56, 184–196 (2012).
  Article CAS PubMed Google Scholar
• Hawksworth, G. M. & Hill, M. J. Bacteria and the N-nitrosation of secondary amines. Br. J. Cancer 25, 520–526 (1971).
  Article CAS PubMed PubMed Central Google Scholar
• Alam, B. S., Saporoschetz, I. B. & Epstein, S. S. Synthesis of nitrosopiperidine from nitrate and piperidine in the gastro-intestinal tract of the rat. Nature 232, 199–200 (1971).
  Article CAS PubMed Google Scholar
• Russell, W. R. et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr. 93, 1062–1072 (2011).
  Article CAS PubMed Google Scholar
• Bindels, L. B. et al. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br. J. Cancer 107, 1337–1344 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Donohoe, D. R. et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell. Metab. 13, 517–526 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hu, S. et al. The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer. PLoS ONE 6, e16221 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Eberhardt, M. V., Lee, C. Y. & Liu, R. H. Antioxidant activity of fresh apples. Nature 405, 903–904 (2000).
  Article CAS PubMed Google Scholar
• DeWeerdt, S. Food: The omnivore's labyrinth. Nature 471, S22–S24 (2011).
  Article CAS PubMed Google Scholar
• Yang, C. S., Wang, X., Lu, G. & Picinich, S. C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nature Rev. Cancer 9, 429–439 (2009).
  Article CAS Google Scholar
• van Duynhoven, J. et al. Metabolic fate of polyphenols in the human superorganism. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4531–4538 (2011).
  Article CAS PubMed Google Scholar
• Fardet, A. et al. Metabolomics provide new insight on the metabolism of dietary phytochemicals in rats. J. Nutr. 138, 1282–1287 (2008).
  Article CAS PubMed Google Scholar
• Dutton, R. J. & Turnbaugh, P. J. Taking a metagenomic view of human nutrition. Curr. Opin. Clin. Nutr. Metab. Care 15, 448–454 (2012).
  Article PubMed Google Scholar
• Chang, M. C. & Keasling, J. D. Production of isoprenoid pharmaceuticals by engineered microbes. Nature Chem. Biol. 2, 674–681 (2006).
  Article CAS Google Scholar
• Mabrok, H. B. et al. Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis 33, 203–208 (2012).
  Article CAS PubMed Google Scholar
• Adlercreutz, H. Phyto-oestrogens and cancer. Lancet Oncol. 3, 364–373 (2002).
  Article PubMed Google Scholar
• Haiser, H. J. & Turnbaugh, P. J. Is it time for a metagenomic basis of therapeutics? Science 336, 1253–1255 (2012).
  Article CAS PubMed Google Scholar
• Wallace, B. D. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831–835 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kassie, F. et al. Intestinal microflora plays a crucial role in the genotoxicity of the cooked food mutagen 2-amino-3-methylimidazo [4,5-f]quinoline. Carcinogenesis 22, 1721–1725 (2001).
  Article CAS PubMed Google Scholar
• Hirayama, K. et al. Effects of human intestinal flora on mutagenicity of and DNA adduct formation from food and environmental mutagens. Carcinogenesis 21, 2105–2111 (2000).
  Article CAS PubMed Google Scholar
• Vanhaecke, L. et al. Intestinal bacteria metabolize the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans. Food Chem. Toxicol. 46, 140–148 (2008).
  Article CAS PubMed Google Scholar
• Sharp, J. O., Wood, T. K. & Alvarez-Cohen, L. Aerobic biodegradation of _N_-nitrosodimethylamine (NDMA) by axenic bacterial strains. Biotechnol. Bioeng. 89, 608–618 (2005).
  Article CAS PubMed Google Scholar
• Seitz, H. K. & Stickel, F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nature Rev. Cancer 7, 599–612 (2007).
  Article CAS Google Scholar
• Seitz, H. K. et al. Possible role of acetaldehyde in ethanol-related rectal cocarcinogenesis in the rat. Gastroenterology 98, 406–413 (1990).
  Article CAS PubMed Google Scholar
• Plottel, C. S. & Blaser, M. J. Microbiome and malignancy. Cell Host Microbe 10, 324–335 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Markle, J. G. et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084–1088 (2013).
  Article CAS PubMed Google Scholar
• Chung, H. et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149, 1578–1593 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Singh, S., Eldin, C., Kowalczewska, M. & Raoult, D. Axenic culture of fastidious and intracellular bacteria. Trends Microbiol. 21, 92–99 (2013).
  Article CAS PubMed Google Scholar
• Bull, A. T. The renaissance of continuous culture in the post-genomics age. J. Ind. Microbiol. Biotechnol. 37, 993–1021 (2010).
  Article CAS PubMed Google Scholar
• Arthur, J. C. & Jobin, C. The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes 4, 253–258 (2013).
  Article PubMed PubMed Central Google Scholar
• Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions between the microbiota and the immune system. Science 336, 1268–1273 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ubeda, C. et al. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J. Exp. Med. 209, 1445–1456 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Shanahan, M. T. et al. Mouse Paneth cell antimicrobial function is independent of Nod2. Gut http://dx.doi.org/10.1136/gutjnl-2012-304190 (2013).
• Robertson, S. J. et al. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes 4, 222–231 (2013).
  Article PubMed PubMed Central Google Scholar
• McCafferty, J. et al. Stochastic changes over time and not founder effects drive cage effects in microbial community assembly in a mouse model. ISME J. http://dx.doi.org/10.1038/ismej.2013.106 (2013).
• Khazaie, K. et al. Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl Acad. Sci. USA 109, 10462–10467 (2012).
  Article CAS PubMed PubMed Central Google Scholar